Back to results
RecruitingPhase 2

The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes

NCT06976619

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Contact

Adrian Vella, MD

507-255-6515vella.adrian@mayo.edu
View on ClinicalTrials.gov
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes — TrialFind